Publications by authors named "Caroline Weipert"

Claim this Profile
C
Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer.
Maxwell R Lloyd, Caroline M Weipert, Azka Ali, Sheila R Solomon, Jayati Saha

Clin Cancer Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired high tumor mutational burden and activity of immunotherapy after targeted therapy in microsatellite stable colorectal cancer.
Celine Yeh, Oliver Artz, Haochen Zhang, Elias-Ramzey Karnoub, Peter Ntiamoah, Caroline Weipert

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer.
Maxwell R Lloyd, Rosario Chica-Parrado, Caroline M Weipert, Todd C Knepper, Emily L Podany

EBioMedicine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer.
Benoit Rousseau, Mitesh Patel, Oliver Artz, Georgios Vlachos, Shrey Patel, Caroline M Weipert

Cancer Cell· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.
Rachel O Abelman, Bogang Wu, Haley Barnes, Arielle Medford, Bryanna Norden, Caroline Weipert

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.
Panagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee, Carolyn Krasner, Susana M Campos, Caroline M Weipert

JCO Precis Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 Inhibitor Efficacy in -Mutant Metastatic Breast Cancer.
Maxwell R Lloyd, Jamie O Brett, Ariel Carmeli, Caroline M Weipert, Nicole Zhang

NEJM Evid· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(HER2) amplifications and co-occurring alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.
Afsaneh Barzi, Caroline M Weipert, Carin R Espenschied, Victoria M Raymond, Andrea Wang-Gillam

Front Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical Outcomes.
Pashtoon Murtaza Kasi, Leslie A Bucheit, Jiemin Liao, Jason Starr, Pedro Barata, Caroline Weipert

JCO Precis Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma.
Joseph W Franses, Mir Lim, Adam M Burgoyne, Kabir Mody, Jochen Lennerz, Caroline M Weipert

Oncologist· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer.
Neelima Vidula, Andrew Lipman, Shumei Kato, Caroline Weipert, Katherine Hesler

NPJ Breast Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interventional pulmonology use of cell-free DNA assay for metastatic non-small cell lung cancer: the UC Davis experience.
Chinh Phan, Forrest Jespersen, Caroline Weipert, Tianhong Li, Ken Y Yoneda

Ther Adv Respir Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations.
Razelle Kurzrock, Charu Aggarwal, Caroline Weipert, Lesli Kiedrowski, Jonathan Riess

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Actionability of Circulating Cell-Free DNA Alterations in Carcinoma of Unknown Primary.
Shumei Kato, Caroline Weipert, Sophia Gumas, Ryosuke Okamura, Suzanna Lee

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878).
Jonathan W Riess, Karen L Reckamp, Paul Frankel, Jeffrey Longmate, Karen A Kelly, Caroline M Weipert

Clin Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma.
Zeynep B Zengin, Caroline Weipert, Nicholas J Salgia, Nazli Dizman, Joann Hsu

Clin Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Genomic Differences in Cell-Free Circulating DNA Profiles of Young- Versus Older-Onset Colorectal Cancer.
Afsaneh Barzi, Caroline M Weipert, Carin R Espenschied, Heinz-Josef Lenz

J Adolesc Young Adult Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis.
Karen L Reckamp, Tejas Patil, Kedar Kirtane, Thereasa A Rich, Carin R Espenschied, Caroline M Weipert

Clin Lung Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.
Allison H West, Kathleen R Blazer, Jessica Stoll, Matthew Jones, Caroline M Weipert

Fam Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.
Vasiliki Panou, Meghana Gadiraju, Arthur Wolin, Caroline M Weipert, Emily Skarda

J Clin Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician Experiences and Understanding of Genomic Sequencing in Oncology.
Caroline M Weipert, Kerry A Ryan, Jessica N Everett, Beverly M Yashar, Arul M Chinnaiyan

J Genet Couns· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
Michael W Drazer, Sabah Kadri, Madina Sukhanova, Sushant A Patil, Allison H West, Caroline M Weipert

Blood Adv· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychosocial Factors Influencing Parental Interest in Genomic Sequencing of Newborns.
Susan E Waisbren, Caroline M Weipert, Rebecca C Walsh, Carter R Petty, Robert C Green

Pediatrics· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis